Gabapentin, once promoted as a safer alternative to opioids for nerve pain, is facing renewed scrutiny. While approved for seizures and shingles pain, it's now widely prescribed off-label for conditions like chronic pain and anxiety. Many patients report severe withdrawal symptoms and side effects, claiming they were not warned about the risks or the need for slow tapering. Research suggests potential issues, with a significant portion of prescriptions being for unapproved uses.